The role of breast MR imaging in preoperative evaluation of disease extent remains controversial. MR imaging increases detection of mammographically occult ipsilateral and contralateral disease, but the clinical impact of these incidental cancers in unknown. There are no randomized trials of recurrence or mortality as the primary end point. This missing evidence is needed before the role of extent of disease MR imaging can be outlined. There are specific clinical scenarios in which breast MR imaging plays a clear role. In most cases, the decision to obtain MR imaging depends on physician practice style and patient preference.
Keywords: Extent of disease; MR imaging; Newly diagnosed.
Copyright © 2017 Elsevier Inc. All rights reserved.